USPTO serial 79229625
REXULTI
Reviewed by CopyMark Law Group
Reg. 5688217Status 709
- Filing date
- Status date
- Registration date
- Mar 5, 2019
- Examiner
- PARK, JENNY K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with REXULTI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kazuyo Morita
Kazuyo Morita Holland & Hart LLPP.O. Box 8749Attn: Trademark DocketingDenver, CO 80201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; Injection devices for medical purposes; syringes and needles for injections and medical purposes; Apparatus and instruments for diagnostic purposes, namely, integrated medical systems comprising medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing, and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks in Class 010
- Similar marks named REXULTI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 19, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 19, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 19, 2025 | C71T | CANCELLED SECTION 71 | — |
| Mar 5, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 12, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 26, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 26, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 5, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 18, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 18, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 15, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 28, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 28, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 28, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 8, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 23, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 23, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 17, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 8, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 23, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 23, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 18, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 17, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 10, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2018 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 5, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |